Molecular Biology Lab Kit market Factors Benefitting Emergence of New Entrants Seegene, SPACEGEN, VITASSAY - openPR
688399 Stock | 70.20 0.17 0.24% |
About 61% of Jiangsu Bioperfectus' investor base is looking to short. The analysis of the overall investor sentiment regarding Jiangsu Bioperfectus Technologies suggests that many traders are alarmed. The current market sentiment, together with Jiangsu Bioperfectus' historical and current headlines, can help investors time the market. In addition, many technical investors use Jiangsu Bioperfectus stock news signals to limit their universe of possible portfolio assets.
Jiangsu |
Molecular Biology Lab Kit market Factors Benefitting Emergence of New Entrants Seegene, SPACEGEN, VITASSAY openPR
Read at news.google.com
Jiangsu Bioperfectus Fundamental Analysis
We analyze Jiangsu Bioperfectus' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jiangsu Bioperfectus using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jiangsu Bioperfectus based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Sales
Price To Sales Comparative Analysis
Jiangsu Bioperfectus is currently under evaluation in price to sales category among its peers. Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Jiangsu Bioperfectus Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jiangsu Bioperfectus stock to make a market-neutral strategy. Peer analysis of Jiangsu Bioperfectus could also be used in its relative valuation, which is a method of valuing Jiangsu Bioperfectus by comparing valuation metrics with similar companies.
Peers
Jiangsu Bioperfectus Related Equities
601628 | China Life | 1.15 | ||||
600938 | CNOOC | 0.61 | ||||
600519 | Kweichow Moutai | 0.51 | ||||
601728 | China Telecom | 0.47 | ||||
600941 | China Mobile | 0.31 | ||||
601668 | China State | 0.17 | ||||
601318 | Ping An | 0.15 | ||||
601857 | PetroChina | 0.12 | ||||
600028 | China Petroleum | 0.63 | ||||
601088 | China Shenhua | 0.77 |
Complementary Tools for Jiangsu Stock analysis
When running Jiangsu Bioperfectus' price analysis, check to measure Jiangsu Bioperfectus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jiangsu Bioperfectus is operating at the current time. Most of Jiangsu Bioperfectus' value examination focuses on studying past and present price action to predict the probability of Jiangsu Bioperfectus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jiangsu Bioperfectus' price. Additionally, you may evaluate how the addition of Jiangsu Bioperfectus to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |